Cargando…

Effect of inactivated COVID-19 vaccine on the negative conversion of nucleic acid in asymptomatic or mild patients with COVID-19

BACKGROUND: Negative conversion of nucleic acid was a key factor in deciding discharge or the end of isolation of asymptomatic or mild COVID-19 patients. We aimed to explore the effect of vaccination on the time to negative conversion after Omicron infection. METHODS: This retrospective cohort study...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yifeng, Zhou, Qian, Huang, Xinyan, Ding, Yuqi, Ye, Xiangrong, Ding, Jie, Kuang, Yukun, Liu, Yihao, Peng, Sui, Zhu, Qingtang, Wang, Haibo, Xiao, Haipeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311841/
https://www.ncbi.nlm.nih.gov/pubmed/37391716
http://dx.doi.org/10.1186/s12879-023-08315-8
_version_ 1785066828103417856
author Luo, Yifeng
Zhou, Qian
Huang, Xinyan
Ding, Yuqi
Ye, Xiangrong
Ding, Jie
Kuang, Yukun
Liu, Yihao
Peng, Sui
Zhu, Qingtang
Wang, Haibo
Xiao, Haipeng
author_facet Luo, Yifeng
Zhou, Qian
Huang, Xinyan
Ding, Yuqi
Ye, Xiangrong
Ding, Jie
Kuang, Yukun
Liu, Yihao
Peng, Sui
Zhu, Qingtang
Wang, Haibo
Xiao, Haipeng
author_sort Luo, Yifeng
collection PubMed
description BACKGROUND: Negative conversion of nucleic acid was a key factor in deciding discharge or the end of isolation of asymptomatic or mild COVID-19 patients. We aimed to explore the effect of vaccination on the time to negative conversion after Omicron infection. METHODS: This retrospective cohort study included asymptomatic or mild patients with COVID-19 admitted to Fangcang shelter Hospital from November 10, 2022 to December 2, 2022. The relationship between vaccination status and the time to negative conversion was analyzed by multiple linear regression. RESULTS: A total of 2,104 asymptomatic or mild COVID-19 patients were included in the analysis, of whom 1,963 were vaccinated. The mean time to negative conversion of no vaccination, one dose, two doses, and three doses were 12.57 (5.05), 12.18 (3.46), 11.67 (4.86) and 11.22 (4.02) days, respectively (p = 0.002). Compared with no vaccination, two doses (β=-0.88, 95% CI: -1.74, -0.02, p = 0.045), and three doses (β=-1.51, 95% CI: -2.33, -0.70, p < 0.001) were both associated with shorter time to negative conversion. Comparing with two doses, booster dose was associated significantly with shorter time to negative conversion (β=-0.63, 95% CI: -1.07, -0.20, p = 0.004). Age was positively correlated with the time to negative conversion (β = 0.04, 95% CI: 0.02, 0.05, p < 0.001). CONCLUSION: Vaccination with inactivated vaccine and booster dose can shorten the time to negative conversion of asymptomatic or mild COVID-19 patients. The significant prolongation of time to negative conversion with increasing age suggests the promotion of vaccination, especially booster dose, particularly in the elderly.
format Online
Article
Text
id pubmed-10311841
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103118412023-07-01 Effect of inactivated COVID-19 vaccine on the negative conversion of nucleic acid in asymptomatic or mild patients with COVID-19 Luo, Yifeng Zhou, Qian Huang, Xinyan Ding, Yuqi Ye, Xiangrong Ding, Jie Kuang, Yukun Liu, Yihao Peng, Sui Zhu, Qingtang Wang, Haibo Xiao, Haipeng BMC Infect Dis Research BACKGROUND: Negative conversion of nucleic acid was a key factor in deciding discharge or the end of isolation of asymptomatic or mild COVID-19 patients. We aimed to explore the effect of vaccination on the time to negative conversion after Omicron infection. METHODS: This retrospective cohort study included asymptomatic or mild patients with COVID-19 admitted to Fangcang shelter Hospital from November 10, 2022 to December 2, 2022. The relationship between vaccination status and the time to negative conversion was analyzed by multiple linear regression. RESULTS: A total of 2,104 asymptomatic or mild COVID-19 patients were included in the analysis, of whom 1,963 were vaccinated. The mean time to negative conversion of no vaccination, one dose, two doses, and three doses were 12.57 (5.05), 12.18 (3.46), 11.67 (4.86) and 11.22 (4.02) days, respectively (p = 0.002). Compared with no vaccination, two doses (β=-0.88, 95% CI: -1.74, -0.02, p = 0.045), and three doses (β=-1.51, 95% CI: -2.33, -0.70, p < 0.001) were both associated with shorter time to negative conversion. Comparing with two doses, booster dose was associated significantly with shorter time to negative conversion (β=-0.63, 95% CI: -1.07, -0.20, p = 0.004). Age was positively correlated with the time to negative conversion (β = 0.04, 95% CI: 0.02, 0.05, p < 0.001). CONCLUSION: Vaccination with inactivated vaccine and booster dose can shorten the time to negative conversion of asymptomatic or mild COVID-19 patients. The significant prolongation of time to negative conversion with increasing age suggests the promotion of vaccination, especially booster dose, particularly in the elderly. BioMed Central 2023-06-30 /pmc/articles/PMC10311841/ /pubmed/37391716 http://dx.doi.org/10.1186/s12879-023-08315-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Luo, Yifeng
Zhou, Qian
Huang, Xinyan
Ding, Yuqi
Ye, Xiangrong
Ding, Jie
Kuang, Yukun
Liu, Yihao
Peng, Sui
Zhu, Qingtang
Wang, Haibo
Xiao, Haipeng
Effect of inactivated COVID-19 vaccine on the negative conversion of nucleic acid in asymptomatic or mild patients with COVID-19
title Effect of inactivated COVID-19 vaccine on the negative conversion of nucleic acid in asymptomatic or mild patients with COVID-19
title_full Effect of inactivated COVID-19 vaccine on the negative conversion of nucleic acid in asymptomatic or mild patients with COVID-19
title_fullStr Effect of inactivated COVID-19 vaccine on the negative conversion of nucleic acid in asymptomatic or mild patients with COVID-19
title_full_unstemmed Effect of inactivated COVID-19 vaccine on the negative conversion of nucleic acid in asymptomatic or mild patients with COVID-19
title_short Effect of inactivated COVID-19 vaccine on the negative conversion of nucleic acid in asymptomatic or mild patients with COVID-19
title_sort effect of inactivated covid-19 vaccine on the negative conversion of nucleic acid in asymptomatic or mild patients with covid-19
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311841/
https://www.ncbi.nlm.nih.gov/pubmed/37391716
http://dx.doi.org/10.1186/s12879-023-08315-8
work_keys_str_mv AT luoyifeng effectofinactivatedcovid19vaccineonthenegativeconversionofnucleicacidinasymptomaticormildpatientswithcovid19
AT zhouqian effectofinactivatedcovid19vaccineonthenegativeconversionofnucleicacidinasymptomaticormildpatientswithcovid19
AT huangxinyan effectofinactivatedcovid19vaccineonthenegativeconversionofnucleicacidinasymptomaticormildpatientswithcovid19
AT dingyuqi effectofinactivatedcovid19vaccineonthenegativeconversionofnucleicacidinasymptomaticormildpatientswithcovid19
AT yexiangrong effectofinactivatedcovid19vaccineonthenegativeconversionofnucleicacidinasymptomaticormildpatientswithcovid19
AT dingjie effectofinactivatedcovid19vaccineonthenegativeconversionofnucleicacidinasymptomaticormildpatientswithcovid19
AT kuangyukun effectofinactivatedcovid19vaccineonthenegativeconversionofnucleicacidinasymptomaticormildpatientswithcovid19
AT liuyihao effectofinactivatedcovid19vaccineonthenegativeconversionofnucleicacidinasymptomaticormildpatientswithcovid19
AT pengsui effectofinactivatedcovid19vaccineonthenegativeconversionofnucleicacidinasymptomaticormildpatientswithcovid19
AT zhuqingtang effectofinactivatedcovid19vaccineonthenegativeconversionofnucleicacidinasymptomaticormildpatientswithcovid19
AT wanghaibo effectofinactivatedcovid19vaccineonthenegativeconversionofnucleicacidinasymptomaticormildpatientswithcovid19
AT xiaohaipeng effectofinactivatedcovid19vaccineonthenegativeconversionofnucleicacidinasymptomaticormildpatientswithcovid19